POD · Class II · 21 CFR 878.4454

FDA Product Code POD: Temporary, Internal Use Hemostatic

Intended To Control Severely Bleeding Wounds

Leading manufacturers include Teleflex Medical.

6
Total
5
Cleared
285d
Avg days
2017
Since
Declining activity - 1 submissions in the last 2 years vs 2 in the prior period
Review times improving: avg 120d recently vs 318d historically

FDA 510(k) Cleared Temporary, Internal Use Hemostatic Devices (Product Code POD)

6 devices
1–6 of 6

About Product Code POD - Regulatory Context

510(k) Submission Activity

6 total 510(k) submissions under product code POD since 2017, with 5 receiving FDA clearance (average review time: 285 days).

Submission volume has declined in recent years - 1 submissions in the last 24 months compared to 2 in the prior period.

FDA Review Time

Recent submissions under POD have taken an average of 120 days to reach a decision - down from 318 days historically, suggesting improved FDA processing for this classification.

POD devices are reviewed by the General & Plastic Surgery panel. Browse all General & Plastic Surgery devices →